Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P?), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Human Coagulation Factor VIII market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Human Coagulation Factor VIII market. Detailed analysis of key players, along with key growth strategies adopted by Human Coagulation Factor VIII industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Grifols
Bayer
Hualan Bio
Pfizer
Kedrion
Greencross
Biogen
Baxter
NovoNordisk
Octapharma
RAAS
CSL
BPL
By Type:
Recombinant Factor VIII
Plasma-derived Factor VIII
By End-User:
Hemophilia A
Spontanous / Trauma
Surgical
Other
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Human Coagulation Factor VIII Market
-
1.3 Market Segment by Type
-
1.3.1 China Human Coagulation Factor VIII Market Size and Growth Rate of Recombinant Factor VIII from 2016 to 2027
-
1.3.2 China Human Coagulation Factor VIII Market Size and Growth Rate of Plasma-derived Factor VIII from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Human Coagulation Factor VIII Market Size and Growth Rate of Hemophilia A from 2016 to 2027
-
1.4.2 China Human Coagulation Factor VIII Market Size and Growth Rate of Spontanous / Trauma from 2016 to 2027
-
1.4.3 China Human Coagulation Factor VIII Market Size and Growth Rate of Surgical from 2016 to 2027
-
1.4.4 China Human Coagulation Factor VIII Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Human Coagulation Factor VIII Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Human Coagulation Factor VIII Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Human Coagulation Factor VIII Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Human Coagulation Factor VIII Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Human Coagulation Factor VIII Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Human Coagulation Factor VIII Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Human Coagulation Factor VIII Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Human Coagulation Factor VIII Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Human Coagulation Factor VIII by Major Types
-
3.4.1 Market Size and Growth Rate of Recombinant Factor VIII
-
3.4.2 Market Size and Growth Rate of Plasma-derived Factor VIII
4 Segmentation of Human Coagulation Factor VIII Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Human Coagulation Factor VIII by Major End-Users
-
4.4.1 Market Size and Growth Rate of Human Coagulation Factor VIII in Hemophilia A
-
4.4.2 Market Size and Growth Rate of Human Coagulation Factor VIII in Spontanous / Trauma
-
4.4.3 Market Size and Growth Rate of Human Coagulation Factor VIII in Surgical
-
4.4.4 Market Size and Growth Rate of Human Coagulation Factor VIII in Other
5 Market Analysis by Regions
-
5.1 China Human Coagulation Factor VIII Production Analysis by Regions
-
5.2 China Human Coagulation Factor VIII Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Human Coagulation Factor VIII Landscape Analysis
-
6.1 North China Human Coagulation Factor VIII Landscape Analysis by Major Types
-
6.2 North China Human Coagulation Factor VIII Landscape Analysis by Major End-Users
7 Central China Human Coagulation Factor VIII Landscape Analysis
-
7.1 Central China Human Coagulation Factor VIII Landscape Analysis by Major Types
-
7.2 Central China Human Coagulation Factor VIII Landscape Analysis by Major End-Users
8 South China Human Coagulation Factor VIII Landscape Analysis
-
8.1 South China Human Coagulation Factor VIII Landscape Analysis by Major Types
-
8.2 South China Human Coagulation Factor VIII Landscape Analysis by Major End-Users
9 East China Human Coagulation Factor VIII Landscape Analysis
-
9.1 East China Human Coagulation Factor VIII Landscape Analysis by Major Types
-
9.2 East China Human Coagulation Factor VIII Landscape Analysis by Major End-Users
10 Northeast China Human Coagulation Factor VIII Landscape Analysis
-
10.1 Northeast China Human Coagulation Factor VIII Landscape Analysis by Major Types
-
10.2 Northeast China Human Coagulation Factor VIII Landscape Analysis by Major End-Users
11 Southwest China Human Coagulation Factor VIII Landscape Analysis
-
11.1 Southwest China Human Coagulation Factor VIII Landscape Analysis by Major Types
-
11.2 Southwest China Human Coagulation Factor VIII Landscape Analysis by Major End-Users
12 Northwest China Human Coagulation Factor VIII Landscape Analysis
-
12.1 Northwest China Human Coagulation Factor VIII Landscape Analysis by Major Types
-
12.2 Northwest China Human Coagulation Factor VIII Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Grifols
-
13.1.1 Grifols Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Bayer
-
13.2.1 Bayer Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Hualan Bio
-
13.3.1 Hualan Bio Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Pfizer
-
13.4.1 Pfizer Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Kedrion
-
13.5.1 Kedrion Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Greencross
-
13.6.1 Greencross Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Biogen
-
13.7.1 Biogen Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Baxter
-
13.8.1 Baxter Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 NovoNordisk
-
13.9.1 NovoNordisk Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Octapharma
-
13.10.1 Octapharma Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 RAAS
-
13.11.1 RAAS Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 CSL
-
13.12.1 CSL Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
-
13.13 BPL
-
13.13.1 BPL Company Profile and Recent Development
-
13.13.2 Market Performance
-
13.13.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Human Coagulation Factor VIII Market Size and Growth Rate of Recombinant Factor VIII from 2016 to 2027
-
Figure China Human Coagulation Factor VIII Market Size and Growth Rate of Plasma-derived Factor VIII from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Human Coagulation Factor VIII Market Size and Growth Rate of Hemophilia A from 2016 to 2027
-
Figure China Human Coagulation Factor VIII Market Size and Growth Rate of Spontanous / Trauma from 2016 to 2027
-
Figure China Human Coagulation Factor VIII Market Size and Growth Rate of Surgical from 2016 to 2027
-
Figure China Human Coagulation Factor VIII Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Human Coagulation Factor VIII Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Human Coagulation Factor VIII Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Human Coagulation Factor VIII Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Human Coagulation Factor VIII Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Human Coagulation Factor VIII Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Human Coagulation Factor VIII Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Human Coagulation Factor VIII Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Human Coagulation Factor VIII Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Human Coagulation Factor VIII
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Human Coagulation Factor VIII by Different Types from 2016 to 2027
-
Table Consumption Share of Human Coagulation Factor VIII by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Recombinant Factor VIII
-
Figure Market Size and Growth Rate of Plasma-derived Factor VIII
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Human Coagulation Factor VIII by Different End-Users from 2016 to 2027
-
Table Consumption Share of Human Coagulation Factor VIII by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hemophilia A
-
Figure Market Size and Growth Rate of Spontanous / Trauma
-
Figure Market Size and Growth Rate of Surgical
-
Figure Market Size and Growth Rate of Other
-
Table China Human Coagulation Factor VIII Production by Regions
-
Table China Human Coagulation Factor VIII Production Share by Regions
-
Figure China Human Coagulation Factor VIII Production Share by Regions in 2016
-
Figure China Human Coagulation Factor VIII Production Share by Regions in 2021
-
Figure China Human Coagulation Factor VIII Production Share by Regions in 2027
-
Table China Human Coagulation Factor VIII Consumption by Regions
-
Table China Human Coagulation Factor VIII Consumption Share by Regions
-
Figure China Human Coagulation Factor VIII Consumption Share by Regions in 2016
-
Figure China Human Coagulation Factor VIII Consumption Share by Regions in 2021
-
Figure China Human Coagulation Factor VIII Consumption Share by Regions in 2027
-
Table North China Human Coagulation Factor VIII Consumption by Types from 2016 to 2027
-
Table North China Human Coagulation Factor VIII Consumption Share by Types from 2016 to 2027
-
Figure North China Human Coagulation Factor VIII Consumption Share by Types in 2016
-
Figure North China Human Coagulation Factor VIII Consumption Share by Types in 2021
-
Figure North China Human Coagulation Factor VIII Consumption Share by Types in 2027
-
Table North China Human Coagulation Factor VIII Consumption by End-Users from 2016 to 2027
-
Table North China Human Coagulation Factor VIII Consumption Share by End-Users from 2016 to 2027
-
Figure North China Human Coagulation Factor VIII Consumption Share by End-Users in 2016
-
Figure North China Human Coagulation Factor VIII Consumption Share by End-Users in 2021
-
Figure North China Human Coagulation Factor VIII Consumption Share by End-Users in 2027
-
Table Central China Human Coagulation Factor VIII Consumption by Types from 2016 to 2027
-
Table Central China Human Coagulation Factor VIII Consumption Share by Types from 2016 to 2027
-
Figure Central China Human Coagulation Factor VIII Consumption Share by Types in 2016
-
Figure Central China Human Coagulation Factor VIII Consumption Share by Types in 2021
-
Figure Central China Human Coagulation Factor VIII Consumption Share by Types in 2027
-
Table Central China Human Coagulation Factor VIII Consumption by End-Users from 2016 to 2027
-
Table Central China Human Coagulation Factor VIII Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Human Coagulation Factor VIII Consumption Share by End-Users in 2016
-
Figure Central China Human Coagulation Factor VIII Consumption Share by End-Users in 2021
-
Figure Central China Human Coagulation Factor VIII Consumption Share by End-Users in 2027
-
Table South China Human Coagulation Factor VIII Consumption by Types from 2016 to 2027
-
Table South China Human Coagulation Factor VIII Consumption Share by Types from 2016 to 2027
-
Figure South China Human Coagulation Factor VIII Consumption Share by Types in 2016
-
Figure South China Human Coagulation Factor VIII Consumption Share by Types in 2021
-
Figure South China Human Coagulation Factor VIII Consumption Share by Types in 2027
-
Table South China Human Coagulation Factor VIII Consumption by End-Users from 2016 to 2027
-
Table South China Human Coagulation Factor VIII Consumption Share by End-Users from 2016 to 2027
-
Figure South China Human Coagulation Factor VIII Consumption Share by End-Users in 2016
-
Figure South China Human Coagulation Factor VIII Consumption Share by End-Users in 2021
-
Figure South China Human Coagulation Factor VIII Consumption Share by End-Users in 2027
-
Table East China Human Coagulation Factor VIII Consumption by Types from 2016 to 2027
-
Table East China Human Coagulation Factor VIII Consumption Share by Types from 2016 to 2027
-
Figure East China Human Coagulation Factor VIII Consumption Share by Types in 2016
-
Figure East China Human Coagulation Factor VIII Consumption Share by Types in 2021
-
Figure East China Human Coagulation Factor VIII Consumption Share by Types in 2027
-
Table East China Human Coagulation Factor VIII Consumption by End-Users from 2016 to 2027
-
Table East China Human Coagulation Factor VIII Consumption Share by End-Users from 2016 to 2027
-
Figure East China Human Coagulation Factor VIII Consumption Share by End-Users in 2016
-
Figure East China Human Coagulation Factor VIII Consumption Share by End-Users in 2021
-
Figure East China Human Coagulation Factor VIII Consumption Share by End-Users in 2027
-
Table Northeast China Human Coagulation Factor VIII Consumption by Types from 2016 to 2027
-
Table Northeast China Human Coagulation Factor VIII Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Human Coagulation Factor VIII Consumption Share by Types in 2016
-
Figure Northeast China Human Coagulation Factor VIII Consumption Share by Types in 2021
-
Figure Northeast China Human Coagulation Factor VIII Consumption Share by Types in 2027
-
Table Northeast China Human Coagulation Factor VIII Consumption by End-Users from 2016 to 2027
-
Table Northeast China Human Coagulation Factor VIII Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Human Coagulation Factor VIII Consumption Share by End-Users in 2016
-
Figure Northeast China Human Coagulation Factor VIII Consumption Share by End-Users in 2021
-
Figure Northeast China Human Coagulation Factor VIII Consumption Share by End-Users in 2027
-
Table Southwest China Human Coagulation Factor VIII Consumption by Types from 2016 to 2027
-
Table Southwest China Human Coagulation Factor VIII Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Human Coagulation Factor VIII Consumption Share by Types in 2016
-
Figure Southwest China Human Coagulation Factor VIII Consumption Share by Types in 2021
-
Figure Southwest China Human Coagulation Factor VIII Consumption Share by Types in 2027
-
Table Southwest China Human Coagulation Factor VIII Consumption by End-Users from 2016 to 2027
-
Table Southwest China Human Coagulation Factor VIII Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Human Coagulation Factor VIII Consumption Share by End-Users in 2016
-
Figure Southwest China Human Coagulation Factor VIII Consumption Share by End-Users in 2021
-
Figure Southwest China Human Coagulation Factor VIII Consumption Share by End-Users in 2027
-
Table Northwest China Human Coagulation Factor VIII Consumption by Types from 2016 to 2027
-
Table Northwest China Human Coagulation Factor VIII Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Human Coagulation Factor VIII Consumption Share by Types in 2016
-
Figure Northwest China Human Coagulation Factor VIII Consumption Share by Types in 2021
-
Figure Northwest China Human Coagulation Factor VIII Consumption Share by Types in 2027
-
Table Northwest China Human Coagulation Factor VIII Consumption by End-Users from 2016 to 2027
-
Table Northwest China Human Coagulation Factor VIII Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Human Coagulation Factor VIII Consumption Share by End-Users in 2016
-
Figure Northwest China Human Coagulation Factor VIII Consumption Share by End-Users in 2021
-
Figure Northwest China Human Coagulation Factor VIII Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Grifols
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Grifols
-
Figure Sales and Growth Rate Analysis of Grifols
-
Figure Revenue and Market Share Analysis of Grifols
-
Table Product and Service Introduction of Grifols
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of Hualan Bio
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hualan Bio
-
Figure Sales and Growth Rate Analysis of Hualan Bio
-
Figure Revenue and Market Share Analysis of Hualan Bio
-
Table Product and Service Introduction of Hualan Bio
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Kedrion
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kedrion
-
Figure Sales and Growth Rate Analysis of Kedrion
-
Figure Revenue and Market Share Analysis of Kedrion
-
Table Product and Service Introduction of Kedrion
-
Table Company Profile and Development Status of Greencross
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Greencross
-
Figure Sales and Growth Rate Analysis of Greencross
-
Figure Revenue and Market Share Analysis of Greencross
-
Table Product and Service Introduction of Greencross
-
Table Company Profile and Development Status of Biogen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen
-
Figure Sales and Growth Rate Analysis of Biogen
-
Figure Revenue and Market Share Analysis of Biogen
-
Table Product and Service Introduction of Biogen
-
Table Company Profile and Development Status of Baxter
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter
-
Figure Sales and Growth Rate Analysis of Baxter
-
Figure Revenue and Market Share Analysis of Baxter
-
Table Product and Service Introduction of Baxter
-
Table Company Profile and Development Status of NovoNordisk
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of NovoNordisk
-
Figure Sales and Growth Rate Analysis of NovoNordisk
-
Figure Revenue and Market Share Analysis of NovoNordisk
-
Table Product and Service Introduction of NovoNordisk
-
Table Company Profile and Development Status of Octapharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Octapharma
-
Figure Sales and Growth Rate Analysis of Octapharma
-
Figure Revenue and Market Share Analysis of Octapharma
-
Table Product and Service Introduction of Octapharma
-
Table Company Profile and Development Status of RAAS
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of RAAS
-
Figure Sales and Growth Rate Analysis of RAAS
-
Figure Revenue and Market Share Analysis of RAAS
-
Table Product and Service Introduction of RAAS
-
Table Company Profile and Development Status of CSL
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL
-
Figure Sales and Growth Rate Analysis of CSL
-
Figure Revenue and Market Share Analysis of CSL
-
Table Product and Service Introduction of CSL
-
Table Company Profile and Development Status of BPL
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BPL
-
Figure Sales and Growth Rate Analysis of BPL
-
Figure Revenue and Market Share Analysis of BPL
-
Table Product and Service Introduction of BPL
-
